Ilker Ates

Prof. Ilker Ates

Pharmaceutical Toxicology, Ankara University, Faculty of Pharmacy, Ankara, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2004 in BioMetals
Verified
Journal Article
Closed access
PDF file
IAIlker Ates
Ilker Ates
HSH. Sinan Suzen
H. Sinan Suzen
AAAhmet Aydin
Ahmet Aydin
AKAsuman Karakaya
Asuman Karakaya

1 July 2004 in Human & Experimental Toxicology
Verified
Journal Article
Closed access
AKAsuman Karakaya
Asuman Karakaya
IAIlker Ates
Ilker Ates
BYBerran Yucesoy
Berran Yucesoy
Polycyclic aromatic hydrocarbons (PAHs) are environmental carcinogens exhibiting potent immunosuppressive properties. In order to determine PAH-induced immunotoxicity in humans, we investigated possible immunomodulating effects on T-lymphocyte proliferative responses and natural killer (NK) cell activities, at two different exposure levels, in asphalt and coke oven workers. We evaluated the efficiency of urinary 1-hy droxypyrene as a measure of exposure to PAHs. We found a statistically significant inhibition in T-lymphocyte proliferative responses of asphalt and coke oven workers compared to the controls. On the other hand, interestingly, we found significantly higher NK cell activities at three effector:target (E:T) ratios in the asphalt group compared to coke oven and control groups. We conclude that PAHs may cause suppression of T-lymphocyte proliferation at both exposure levels and augment NK cell activity only at low levels of exposure. Our results are in line with others reported in the literature indicating that chronic exposure to PAHs at different levels may alter some immune responses in different ways.

1 January 2011 in Experimental and Toxicologic Pathology
Verified
Journal Article
Closed access
IAIlker Ates
Ilker Ates
BYBerran Yucesoy
Berran Yucesoy
AYAysegul Atak Yucel
Aysegul Atak Yucel
SSSinan H. Suzen
Sinan H. Suzen
YKYalcin Karakas
Yalcin Karakas
AKAsuman Karakaya
Asuman Karakaya

4 September 2008 in American Journal of Industrial Medicine
Verified
Journal Article
Closed access
PDF file
IAIlker Ates
Ilker Ates
HSH. Sinan Suzen
H. Sinan Suzen
BYBerran Yucesoy
Berran Yucesoy
ITIshak Ozel Tekin
Ishak Ozel Tekin
AKAsuman Karakaya
Asuman Karakaya

3 December 2025 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
RTRamazan Tunc
Ramazan Tunc
IAIlker Ates
Ilker Ates
BYBeyza Yılmaz
Beyza Yılmaz
AMAlessandro Medoro
Alessandro Medoro
SDSergio Davinelli
Sergio Davinelli
LSLuciano Saso
Luciano Saso
Nuclear factor erythroid 2–related factor 2 (Nrf2) is a key transcription factor that regulates the expression of genes involved in cellular protection against oxidative stress and the maintenance of redox homeostasis. In addition to modulating reactive oxygen species (ROS), Nrf2 influences lipid peroxidation (LP) and ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxide accumulation. Dysregulation of Nrf2 signaling has been implicated in the pathogenesis and progression of several malignancies, where it affects tumor cell survival, chemoresistance, and metabolic reprogramming. This review summarizes current knowledge on the complex relationship between Nrf2 activity, LP dynamics, and ferroptotic mechanisms in cancer biology. It also highlights how Nrf2-dependent transcriptional programs not only regulate antioxidant responses but also contribute to cellular detoxification, metabolism, autophagy, and proteostasis, processes closely linked to tumorigenesis and cancer cell adaptability. Given that Nrf2 may have a dual role in cancer, either promoting cytoprotection or supporting tumor progression and chemoresistance, we discuss emerging strategies to selectively modulate Nrf2 and ferroptosis-related pathways to increase cancer cell sensitivity to oxidative damage and reduce resistance.

30 April 2011 in Clinical Biochemistry
Verified
Journal Article
Closed access
DADurdu Altuner
Durdu Altuner
SSSinan H. Suzen
Sinan H. Suzen
IAIlker Ates
Ilker Ates
GKGonul V. Koc
Gonul V. Koc
YAYalcin Aral
Yalcin Aral
AKAsuman Karakaya
Asuman Karakaya